227 related articles for article (PubMed ID: 23936756)
1. Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing).
Piccini JP; Hellkamp AS; Whellan DJ; Ellis SJ; Keteyian SJ; Kraus WE; Hernandez AF; Daubert JP; Piña lL; O'Connor CM;
JACC Heart Fail; 2013 Apr; 1(2):142-8. PubMed ID: 23936756
[TBL] [Abstract][Full Text] [Related]
2. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Exercise Training in Patients With an Implantable Cardioverter-Defibrillator: A Meta-Analysis.
Pandey A; Parashar A; Moore C; Ngo C; Salahuddin U; Bhargava M; Kumbhani DJ; Piccini JP; Fonarow GC; Berry JD
JACC Clin Electrophysiol; 2017 Feb; 3(2):117-126. PubMed ID: 29759383
[TBL] [Abstract][Full Text] [Related]
4. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
O'Connor CM; Whellan DJ; Lee KL; Keteyian SJ; Cooper LS; Ellis SJ; Leifer ES; Kraus WE; Kitzman DW; Blumenthal JA; Rendall DS; Miller NH; Fleg JL; Schulman KA; McKelvie RS; Zannad F; Piña IL;
JAMA; 2009 Apr; 301(14):1439-50. PubMed ID: 19351941
[TBL] [Abstract][Full Text] [Related]
6. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
7. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
[TBL] [Abstract][Full Text] [Related]
8. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.
Ambrosy AP; Bhatt AS; Stebbins AL; Wruck LM; Fudim M; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Mentz RJ
Am Heart J; 2018 May; 199():97-104. PubMed ID: 29754673
[TBL] [Abstract][Full Text] [Related]
9. Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients.
Smit MD; Van Dessel PF; Nieuwland W; Wiesfeld AC; Tan ES; Anthonio RL; Van Erven L; Van Veldhuisen DJ; Van Gelder IC
Heart Rhythm; 2006 Dec; 3(12):1397-403. PubMed ID: 17161779
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
12. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.
Bunch TJ; Day JD; Olshansky B; Stolen KQ; Mullin CM;
Heart Rhythm; 2009 Jan; 6(1):2-8. PubMed ID: 18996055
[TBL] [Abstract][Full Text] [Related]
13. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
14. Predictors of implantable cardioverter defibrillator shocks during the first year.
Dougherty CM; Hunziker J
J Cardiovasc Nurs; 2009; 24(1):21-8; quiz 29-30. PubMed ID: 19114797
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of defibrillator shocks in patients with heart failure.
Poole JE; Johnson GW; Hellkamp AS; Anderson J; Callans DJ; Raitt MH; Reddy RK; Marchlinski FE; Yee R; Guarnieri T; Talajic M; Wilber DJ; Fishbein DP; Packer DL; Mark DB; Lee KL; Bardy GH
N Engl J Med; 2008 Sep; 359(10):1009-17. PubMed ID: 18768944
[TBL] [Abstract][Full Text] [Related]
16. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators.
Bhavnani SP; Kluger J; Coleman CI; White CM; Guertin D; Shafi NA; Yarlagadda RK; Clyne CA
Heart Rhythm; 2010 Jun; 7(6):755-60. PubMed ID: 20211275
[TBL] [Abstract][Full Text] [Related]
18. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
20. Clinical factors associated with baseline history of atrial fibrillation and subsequent clinical outcomes following initial implantable cardioverter-defibrillator placement.
Giancaterino S; Nishimura M; Birgersdotter-Green U; Hoffmayer KS; Han FT; Raissi F; Ho G; Krummen D; Feld GK; Hsu JC
Pacing Clin Electrophysiol; 2020 Jun; 43(6):542-550. PubMed ID: 32297348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
